Dosidal · Switzerland

Boostrix Polio, Injektionssuspension

Dosidal is a product record. It identifies a medicine and its regulatory status. It does not advise on use.

MarketSwitzerland
Recordch:authorisation:681 (version 1)
Levelauthorisation
Pack codenot anchored
Identifiersswissmedic-authorisation: 681
atc: J07CA02
Source authoritySwissmedic
Read date
authorisation statusfirst_authorisation: 2004-04-01
term: zugelassen
valid_until: 9999-12-31
state: current · read 2026-11-15T01:25:13Z · source: Swissmedic (OGD) page
identityatc: J07CA02
authorisation_number: 681
form: SUPA
holder: GlaxoSmithKline AG
holder_partner_nr: 1000930
it_number: 08.08.
name: Boostrix Polio, Injektionssuspension
state: current · read 2026-11-15T01:25:13Z · source: Swissmedic (OGD) page
SignatureES256 over JCS, key dosidal-record-1.9dbf5d53
7OSxv_df5Ta472IhBsVnWm7H58Y8JJErk2pz_V6uRAVmCdS2ATqqbvx0jb4b-RtfPrZGrloSzRXbrWdQ0tNdXQ
Verify with verify_record (MCP) or POST https://dosidal-api.ai/v1/verify/record; keyring https://dosidal-registry.ai/.well-known/jwks.json

JSON: https://dosidal-api.ai/v1/records/ch:authorisation:681 · Same medicine in other markets · Dosidal